PIS
GSK icon

POM Investment Strategies’s GSK GSK Stock Holding History

POM Investment Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,501
Closed -$138K – 389
2026
Q1 		$138K Buy
2,501
+2,489
+20,742% +$135K 0.17% 64
2025
Q4 		$588 Hold
12
– – ﹤0.01% 320
2025
Q3 		$518 Buy
+12
New +$469 ﹤0.01% 189
2025
Q1 		– Sell
-5,171
Closed -$175K – 273
2024
Q4 		$175K Sell
5,171
-10
-0.2% -$360 0.13% 34
2024
Q3 		$212K Sell
5,181
-379
-7% -$15.5K 0.17% 30
2024
Q2 		$214K Buy
5,560
+389
+8% +$16.4K 0.17% 30
2024
Q1 		$222K Hold
5,171
– – 0.18% 32
2023
Q4 		$192K Buy
+5,171
New +$186K 0.18% 34

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

POM Investment Strategies's GSK Position: Q2 2026 in Review

POM Investment Strategies sold out of GSK (GSK) in Q2 2026, closing a stake of 2,501 shares — an estimated $138K sold.

POM Investment Strategies first reported a position in GSK in Q4 2023 and held it in 8 quarters. The position peaked at $222K in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • POM Investment Strategies reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • POM Investment Strategies sold 2,501 GSK shares in Q2 2026, an estimated $138K.
  • POM Investment Strategies first reported a position in GSK in Q4 2023 and held it in 8 quarters.
  • POM Investment Strategies's GSK position peaked at $222K in Q1 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.